{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:09:46Z","timestamp":1768532986349,"version":"3.49.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2,1]]},"DOI":"10.2146\/ajhp080603","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T00:28:00Z","timestamp":1264465680000},"page":"206-213","source":"Crossref","is-referenced-by-count":62,"title":["Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature"],"prefix":"10.1093","volume":"67","author":[{"given":"Kristina E.","family":"Ward","sequence":"first","affiliation":[{"name":"College of Pharmacy, University of Rhode Island, Kingston. LT USN MSC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raoul","family":"Archambault","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Robert E. Bush Naval Hospital, Twentynine Palms, CA; at the time of writing he was a student, College of Pharmacy, University of Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey L.","family":"Mersfelder","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Ferris State University, Kalamazoo, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041104232869600_b1-0670206","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1023\/A:1012351231143","article-title":"Stevens Johnson syndrome and cholestatic hepatitis","volume":"46","author":"Morelli","year":"2001","journal-title":"Dig Dis Sci"},{"key":"key\n\t\t\t\t2019041104232869600_b2-0670206","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104232869600_b3-0670206","first-page":"2234","article-title":"The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal anti-inflammatory drugs: a multinational prospective","volume":"30","author":"Mockenhaupt","year":"2003","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2019041104232869600_b4-0670206","first-page":"766","article-title":"Sulindac-induced toxic epidermal necrolysis","volume":"7","author":"Small","year":"1988","journal-title":"Clin Pharm"},{"key":"key\n\t\t\t\t2019041104232869600_b5-0670206","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archderm.1991.01680050075007","article-title":"A population-based study of Stevens-Johnson syndrome: incidence and antecedent drug exposures","volume":"127","author":"Strom","year":"1991","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t2019041104232869600_b6-0670206","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.1990.01670250049006","article-title":"The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: a population-based study with particular reference to reactions caused by drugs among outpatients","volume":"126","author":"Chan","year":"1990","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t2019041104232869600_b7-0670206","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2165\/00002018-199106030-00007","article-title":"A case of Stevens-Johnson syndrome, cholestatic hepatitis and haemolytic anaemia associated with use of mefenamic acid","volume":"16","author":"Chan","year":"1991","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t2019041104232869600_b8-0670206","unstructured":"Food and Drug Administration. FDA issues public health advisory on Vioxx as its manufacturer voluntarily withdraws the product. www.fda.gov\/bbs\/topics\/news\/2004\/NEW01122.html (accessed 2007 Nov 14)."},{"key":"key\n\t\t\t\t2019041104232869600_b9-0670206","unstructured":"Food and Drug Administration. Alert for healthcare professionals: celecoxib (marketed as Celebrex). www.fda.gov\/cder\/drug\/infopage\/celebrex\/celebrex-hcp.pdf (accessed 2007 Nov 14)."},{"key":"key\n\t\t\t\t2019041104232869600_b10-0670206","unstructured":"Food and Drug Administration. FDA talk paper: Bextra label updated with boxed warning concerning severe skin reactions and warning regarding cardiovascular risk. www.fda.gov\/bbs\/topics\/ANSWERS\/2004\/ANS01331.html (accessed 2005 Dec 11)."},{"key":"key\n\t\t\t\t2019041104232869600_b11-0670206","unstructured":"Gardner A . Ibuprofen controversy continues after COX-2 hearings. www.hon.ch\/News\/HSN\/524149.html (accessed 2005 Dec 11)."},{"key":"key\n\t\t\t\t2019041104232869600_b12-0670206","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archderm.1987.01660330077013","article-title":"The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell\u2019s syndrome)","volume":"123","author":"Guillaume","year":"1987","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t2019041104232869600_b13-0670206","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archderm.1991.01680050083008","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: an epidemiologic study from West Germany","volume":"127","author":"Schopf","year":"1991","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t2019041104232869600_b14-0670206","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t2019041104232869600_b15-0670206","unstructured":"World Health Organization. About the ATC\/DDD system. www.whocc.no\/atcddd\/atcsystem.html (accessed 2007 Nov 19)."},{"key":"key\n\t\t\t\t2019041104232869600_b16-0670206","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041104232869600_b17-0670206","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2165\/00002018-200528100-00008","article-title":"Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors","volume":"28","author":"La Grenade","year":"2005","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t2019041104232869600_b18-0670206","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00200472","article-title":"A fatal case of sulindac-induced Lyell syndrome (toxic epidermal necrolysis)","volume":"98","author":"Ikeda","year":"1987","journal-title":"Z Rechtsmed"},{"key":"key\n\t\t\t\t2019041104232869600_b19-0670206","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000234043","article-title":"Toxic epidermal necrolysis with extensive mucosal erosions of the gastrointestinal and respiratory tracts","volume":"80","author":"Roupe","year":"1986","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"key\n\t\t\t\t2019041104232869600_b20-0670206","first-page":"512","article-title":"Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy","volume":"10","author":"Klein","year":"1983","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2019041104232869600_b21-0670206","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/archinte.1982.00340200050013","article-title":"Serious adverse reactions associated with sulindac","volume":"142","author":"Park","year":"1982","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041104232869600_b22-0670206","first-page":"193","article-title":"Stevens-Johnson syndrome due to sulindac: a case report and review of literature","volume":"53","author":"Maguire","year":"1981","journal-title":"Del Med J"},{"key":"key\n\t\t\t\t2019041104232869600_b23-0670206","first-page":"176","article-title":"Sulindac-induced Stevens-Johnson syndrome: a report of 3 cases","volume":"8","author":"Husain","year":"1981","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2019041104232869600_b24-0670206","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jama.1980.03300380042021","article-title":"Sulindac-induced Stevens-Johnson toxic epidermal necrolysis syndrome","volume":"243","author":"Levitt","year":"1980","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041104232869600_b25-0670206","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/rheumatology\/22.1.47","article-title":"A case of toxic epidermal necrolysis secondary to indomethacin","volume":"22","author":"O\u2019Sullivan","year":"1983","journal-title":"Br J Rheumatol"},{"key":"key\n\t\t\t\t2019041104232869600_b26-0670206","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/pgmj.72.845.186-a","article-title":"Toxic epidermal necrolysis associated with indomethacin therapy","volume":"72","author":"Lear","year":"1996","journal-title":"Postgrad Med J"},{"issue":"4, pt 1","key":"key\n\t\t\t\t2019041104232869600_b27-0670206","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0190-9622(88)80190-7","article-title":"Fenoprofen-induced toxic epidermal necrolysis","volume":"18","author":"Stotts","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2019041104232869600_b28-0670206","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpeds.2004.05.027","article-title":"Acute vanishing bile duct syndrome after ibuprofen therapy in a child","volume":"145","author":"Taghian","year":"2004","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041104232869600_b29-0670206","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0016-5085(98)70154-4","article-title":"Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndrome in a child","volume":"115","author":"Srivastava","year":"1998","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019041104232869600_b30-0670206","first-page":"1239","article-title":"Stevens-Johnson syndrome plus toxic hepatitis due to ibuprofen","volume":"78","author":"Sternlieb","year":"1978","journal-title":"N Y State J Med"},{"key":"key\n\t\t\t\t2019041104232869600_b31-0670206","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000246675","article-title":"Toxic epidermal necrolysis related to ketoprofen","volume":"190","author":"Tijhuis","year":"1995","journal-title":"Dermatology"},{"key":"key\n\t\t\t\t2019041104232869600_b32-0670206","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archpedi.160.8.801","article-title":"Picture of the month. Stevens-Johnson syndrome","volume":"160","author":"Reichenberg","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"key\n\t\t\t\t2019041104232869600_b33-0670206","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0781.2005.00149.x","article-title":"A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin","volume":"21","author":"Mansur","year":"2005","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"key\n\t\t\t\t2019041104232869600_b34-0670206","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1191\/0961203304lu2037sa","article-title":"Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions","volume":"13","author":"Ting","year":"2004","journal-title":"Lupus"},{"key":"key\n\t\t\t\t2019041104232869600_b35-0670206","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archotol.124.12.1375","article-title":"Hypopharyngeal stenosis and dysphagia complicating toxic epidermal necrolysis","volume":"124","author":"Barrera","year":"1998","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"key\n\t\t\t\t2019041104232869600_b36-0670206","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10353-005-0194-8","article-title":"Naproxen sodium-induced toxic epidermal necrolysis: a case report and review of the literature","volume":"37","author":"Kalemoglu","year":"2005","journal-title":"Eur Surg"},{"key":"key\n\t\t\t\t2019041104232869600_b37-0670206","first-page":"233","article-title":"Toxic epidermal necrolysis following treatment with oxaprozin","volume":"38","author":"Carucci","year":"1999","journal-title":"Int J Dermatol"},{"key":"key\n\t\t\t\t2019041104232869600_b38-0670206","first-page":"2026","article-title":"A case of Stevens-Johnson syndrome associated with oxaprozin therapy","volume":"25","author":"Bell","year":"1998","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2019041104232869600_b39-0670206","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00004630-199807000-00009","article-title":"Case report: oxaprozin and fatal toxic epidermal necrolysis","volume":"19","author":"Paul","year":"1998","journal-title":"J Burn Care Rehabil"},{"key":"key\n\t\t\t\t2019041104232869600_b40-0670206","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1081-1206(10)62830-X","article-title":"Facial edema, oral ulcers, and a cutaneous eruption following a dental procedure utilizing diflunisal and mepivacaine","volume":"83","author":"Yusin","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key\n\t\t\t\t2019041104232869600_b41-0670206","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.2.6144.1088-c","article-title":"Diflunisal and Stevens-Johnson syndrome","volume":"2","author":"Hunter","year":"1978","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t2019041104232869600_b42-0670206","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2165\/00002018-200629080-00005","article-title":"Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England","volume":"29","author":"Layton","year":"2006","journal-title":"Drug Saf"},{"key":"key\n\t\t\t\t2019041104232869600_b43-0670206","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1592\/phco.22.13.1193.33513","article-title":"Toxic epidermal necrolysis after celecoxib therapy","volume":"22","author":"Berger","year":"2002","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019041104232869600_b44-0670206","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/00007611-200295100-00023","article-title":"Toxic epidermal necrolysis due to administration of celecoxib (Celebrex)","volume":"95","author":"Friedman","year":"2002","journal-title":"South Med J"},{"issue":"5","key":"key\n\t\t\t\t2019041104232869600_b45-0670206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5070\/D328F2D7GX","article-title":"Toxic epidermal necrolysis as a complication of treatment with celecoxib","volume":"9","author":"Perna","year":"2003","journal-title":"Dermatol Online J"},{"key":"key\n\t\t\t\t2019041104232869600_b46-0670206","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.ico.0000126330.77228.a3","article-title":"A case of rofecoxib-associated Stevens-Johnson syndrome with corneal and conjunctival changes","volume":"23","author":"Goldberg","year":"2004","journal-title":"Cornea"},{"key":"key\n\t\t\t\t2019041104232869600_b47-0670206","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1592\/phco.23.4.551.32118","article-title":"Valdecoxib-induced toxic epidermal necrolysis in a patient allergic to sulfa drugs","volume":"23","author":"Glasser","year":"2003","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019041104232869600_b48-0670206","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/pds.755","article-title":"Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III)","volume":"12","author":"Paulose-Ram","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/67\/3\/206\/28343427\/ajhp0206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T19:48:44Z","timestamp":1634759324000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/67\/3\/206\/5130006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,1]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,2,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp080603","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,2,1]]},"published":{"date-parts":[[2010,2,1]]}}}